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Abstract

Background and Purpose: The strong influence of physician recommendation on vaccine uptake is well
established in the literature. However, its influence on HPV vaccine decision-making among young
Haitian women is understudied. This study investigated the role of healthcare providers’ recommendation
style in Haitian parents’ and female patients’ HPV vaccine decision-making. Methods: Thirty selfidentified Haitian women aged 17-26 years were recruited from a large university campus in the
Southeastern United States (N=30). They completed in-depth face-to-face interviews regarding their HPV
vaccine decision-making process. Transcripts were analyzed using thematic analysis. Results: Provider
recommendation was cited as a major factor that influenced HPV vaccine uptake. Additionally, the
framing of the HPV vaccine message greatly influenced vaccine decisions. Messages that framed the
vaccine as a preventive measure for cervical cancer or as a preventive vaccine without an emphasis on the
sexual transmission route of the virus were most effective. Messages that framed the vaccine as a
preventive measure against a sexually transmitted infection did not positively influence young women to
be vaccinated. Conclusions: These findings indicate that providers’ recommendation style highly affects
HPV vaccine decision. Thus, appropriate HPV vaccine framing is important for encouraging vaccine
uptake in this ethnic group.
© 2017 Californian Journal of Health Promotion. All rights reserved.
Keywords: HPV vaccine; Haitian; healthcare providers; recommendation style; and decision-making

Background
Human papillomavirus (HPV) is the most
common sexually transmitted infection (STI)
(Centers for Disease Control and Prevention,
2016), and has been causally linked to
oropharyngeal and anogenital cancers (Bosch,
Lorincz, Muñoz, Meijer, & Shah, 2002; Jones,
Rowan, & Stewart, 2005). About half of all new
HPV infections occur among individuals aged
15−24 years (Centers for Disease Control and
Prevention, 2016). The United States Federal
Drug Administration licensed the first HPV
preventive vaccine in 2006 (Centers for Disease
Control and Prevention, 2010), and the vaccine
confers protection against HPV strains that
cause about 70% of HPV-related cancers
(Dempsey, Abraham, Dalton, & Ruffin, 2009).

The vaccine has a three-dose schedule and is
recommended for boys and girls age 11−12
years. Catch-up vaccination is available until the
age of 26 (Centers for Disease Control and
Prevention, 2012). Additionally, the United
States Healthy People 2020 has a goal of 80%
coverage for HPV vaccination (U.S. Department
of Health and Human Services, 2014), but
currently, the overall vaccination rate is about
49% among women aged 18-26 years (Cohen,
Legg, Hutchinson, Levy, & Bosher, 2015).
Haiti has one of the highest cervical cancer
incidence and the highest associated mortality in
the Western Hemisphere (International Agency
for Research on Cancer, 2014). Lack of
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nationally
implemented
cervical
cancer
screening programs contribute largely to the
higher incidence and mortality experienced by
Haitian women (Pan American Health
Organization & World Health Organization,
2008). Haitian women residing in the United
States (U.S.) continue to experience a
disproportionate burden of cervical cancer
despite the increased availability of screening
services (Kobetz, Mendoza, & Menard, 2010).
For example, for the 2000−2004 period, the
incidence of cervical cancer was 9.1/100,000 for
the state of Florida while the incidence was
38.0/100,000 in Little Haiti, a Haitian
community in Miami, Florida (Florida Charts,
2014). During their young adulthood, Haitian
women are at high risk of acquiring HPV
infections (Centers for Disease Control and
Prevention, 2016). Moreover, Haitian women
experience unique cultural and important socioeconomic factors that contribute to an increased
risk of developing cervical cancer in the future
(Pan American Health Organization & World
Health Organization, 2008;Stephens & Thomas,
2013).

& Crandall, 2005; Schnepel, 2007) and were
more likely to have their adolescent daughters
vaccinated against HPV, if recommended by a
provider (Pierre Joseph et al., 2012; Stephens &
Thomas, 2013; Wilson, Brown, Boothe, &
Harris, 2013). Additionally, healthcare providers
serve as the primary source of health
information for Haitian mothers (Pierre Joseph
et al., 2012). Therefore, they may play a major
role in HPV vaccine adoption among young
Haitian women.
For any ethnic group, cultural beliefs directly or
indirectly affect the acceptance of health
messages and the adoption of promoted health
behaviors (Hecht & Krieger, 2006; Kreuter &
Mcclure, 2004). When a health promotion
message is congruent with a group’s cultural
beliefs, group members are more likely to accept
the message (Institute of Medicine, 2002;
Kreuter & Mcclure, 2004). Although parents
across cultures view healthcare providers as a
trusted source of health information and highly
value their recommendation for the HPV
vaccine, previous research has reported cultural
differences in acceptance of the HPV vaccine
based on the message framing (Lechuga, Swain,
& Weinhardt, 2011; Nan, 2012; Petrova et al.,
2015). Given the high prevalence of cervical
cancer among Haitian women, identifying HPV
recommendation framings that are appropriate
for this group can help increase HPV vaccine
uptake. Hence, this study explored the role of
healthcare providers’ recommendation style in
Haitian parents’ and female patients’ HPV
vaccine decision-making.

Physician recommendation for the HPV vaccine
has been identified as a strong predictor of HPV
vaccination among adolescents
(Jeudin,
Liveright, Del Carmen, & Perkins, 2014; Mazza,
Petrovic, & Chakraborty, 2012; Perkins, Brogly,
Adams, & Freund, 2012; Reiter, Katz, &
Paskett, 2013; Stephens & Thomas, 2013;
Vadaparampil et al., 2014). Mothers are usually
the parent responsible for vaccine decisionmaking. Therefore, mother-clinician interactions
are among the factors that influence mothers’
decision to allow their adolescent daughters to
be vaccinated against HPV (Griffioen et al.,
2013). Among young women, provider
recommendation for the vaccine has been
identified as a facilitator of HPV vaccine uptake
(Chao, Velicer, Slezak, & Jacobsen, 2010;
Hopfer & Clippard, 2011; Moore, Crosby,
Young, & Charnigo, 2010; Rosenthal et al.,
2011).

Methods
We sought to understand the role of providers’
recommendation style in Haitian parents’ and
female patients’ HPV vaccine decision-making
processes and to obtain a rich description of
their HPV decision-making processes in a
cultural context. Qualitative approaches allow
for more in-depth and nuanced description of
participants’ and parents’ decision-making
processes as they relate to the messages used by
their health care providers.

Previous studies have suggested that Haitian
parents highly valued the knowledge and
recommendations of healthcare providers (Ryan,
Hawkins, Parker, & Hawkins, 2004; Saint-Jean
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research in the field (Stephens & Thomas, 2013;
Wilson et al., 2013), interviews began with
questions to establish HPV vaccination
knowledge and beliefs (Appendix I). The
interview captured participants’ HPV infection
and vaccine knowledge, source of information,
HPV vaccine perceptions and attitudes,
vaccination status, HPV vaccine facilitators, and
barriers to HPV vaccination. More time was
dedicated toward HPV vaccine facilitators (for
those who have been vaccinated), barriers to
HPV vaccination (for those who were not
vaccinated), and decision-making process
compared to other constructs. Interview
questions included: Have you ever heard of
Human Papillomavirus or HPV? Where/how did
you hear about it? What do you know about the
vaccine? Where/how did you get this
information? Who should get the HPV vaccine?
Have you initiated the HPV vaccine series?
What/who motivated you to get the vaccine? And
what/who do you think influenced you to not get
the vaccine?

Participants
Recruitment for this study took place at a large
minority-serving university in Southeastern
United States. Thirty participants were recruited
via an online psychology research pool known
as ‘Sona’. Through Sona, students enrolled in
psychology courses were screened for eligibility
prior to scheduling their interviews; criteria
included self-identifying as Haitian, female, and
being between 17 and 26 years of age. We
wanted to interview Haitian females who were
still eligible for the vaccine, as indicated by the
Advisory Committee on Immunization Practices
guidelines (Centers for Disease Control and
Prevention, 2013). We sought to interview
vaccinated and unvaccinated Haitian females,
whether the decision was made by their parents
(with or without their input) or by themselves as
young adults. Therefore, potential participants
were not screened based on HPV vaccination
status and timing of vaccine uptake. Females
who were no longer eligible for the vaccine
(older than 26 years) and those who did not selfidentify as Haitian or Haitian American were
restricted from signing up for the study in Sona.

Interviews were conducted in a private
conference room; with each session audio-taped,
with the shortest interview lasting 15 and the
longest lasting 65 minutes. Interview length
varied by participants’ level of HPV awareness,
experience with HPV vaccine messages, and
decision-making process. The interviews were
conducted in English, between June 2014 and
March 2015.

Procedures
The principal investigator conducted the
individual interviews at a time selected by the
participants. Study participants underwent a
consent process which included reading the
letter of consent approved by the university’s
Internal Review Board and asking questions to
the principal investigator. Participants then
completed a demographic questionnaire that
collected the participant’s age, self-identity,
current class standing, country of birth, number
of years in the U.S., and parents’ country of
birth. For the few participants who were younger
than 18, their parent’s consent was obtained
prior to the interview.

Data Analyses
A thematic analysis was undertaken. Data
collection
and
analysis
proceeded
simultaneously (Corbin & Strauss, 2014). The
interviews were transcribed, and then verified by
one study investigator to ensure completeness,
accuracy of the discussion content, and a high
quality of transcription. A preliminary coding
framework related to HPV vaccine knowledge
and attitudes was constructed by three study
authors after an in-depth reading of the
transcripts. Themes identified in this first stage
were not specified a priori but rather were
derived from the data. Meaningful units were
selected by the research team, these units were
coded and used to develop the preliminary
coding framework. Codes were then used to

A series of semi-structured yet flexible questions
were developed based on qualitative HPV
vaccine research conducted among college
students (Hopfer & Clippard, 2011), Haitian and
African American parents (Pierre Joseph et al.,
2012), Haitian parents (Stephens & Thomas,
2013), and ethnically diverse Black women
(Wilson et al., 2013). Similar to previous
70

Pierre-Victor, D., Stephens, D., Clarke, R., Gabbidon, K., Madhivanan, P./ Californian Journal of Health Promotion 2017, Volume
15, Issue 3, Pages 68-80.

develop overarching themes. Additional codes
were developed inductively and new themes
emerge through the analysis process. Themes
and subthemes were then examined across the
whole dataset, and in relation to each specific
interview. The research team used a process of
negotiated agreement to determine inter-rater
agreement which included meeting to discuss
and further refine each set of themes, resolved
differences, and reached consensus on a coding
scheme. Discrepancies were resolved by first
revisiting and reviewing the data, and then
through group discussion. Key themes were
summarized, reviewed, and agreed upon by the
research team.

healthcare providers. The results presented
below are from the 16 participants who have
received a provider recommendation for the
vaccine.
Table 1
Demographic
Characteristics
Participants
Characteristics
Self-Identity
Haitian
Haitian-American
Class Standing
Seniors /Graduate
Sophomore/Junior
Freshman
Country of Birth
USA
Haiti
HPV Vaccination Status
Unvaccinated
Initiated series
Completed series

Results
A total of 30 young women with a median age
of 21 participated in the study. Although ten of
the participants were born abroad, only four had
been living in the United States for fewer than
ten years. Eighteen had not received the vaccine,
eight had begun the HPV vaccine series, and
four had completed the series (Table 1). The
results presented here are organized around three
major themes identified in the analysis of the
role of healthcare providers’ recommendation
style in Haitian parents’ and female patients’
HPV vaccine decision-making: 1) provider
recommendation, 2) HPV vaccine message
framing, and 3) vaccine decision. The message
framing and the decision following the vaccine
recommendation are presented jointly. For the
purposes of this study, a HPV vaccine
recommendation is defined as: 1) any discussion
in which a healthcare provider informs the
patient and/or parents about the vaccine and 2)
offers the vaccine, positively endorses it, or
directly recommends it. Following each quote,
the participant’s status for parental consent at the
time of the recommendation is provided.

of

Study

n

%

10
20

33
67

15
5
10

50
17
33

23
7

70
30

18
8
4

60
27
13

Twelve of the 16 participants who have received
at least one provider recommendation for the
vaccine were vaccinated. When asked about who
or what motivated them to get the vaccine
(n=12), one stated she received it because her
school required it, and the other 11 cited
healthcare provider recommendation among the
factors that highly motivated them to take the
vaccine. Most participants who had HPV
vaccine discussion had it with a physician
(n=13), and a few young women had such
discussion with a nurse (n=3). Two participants
stated that they received a recommendation for
the vaccine on two separate occasions.
The doctor said it [the vaccine] was
recommended. (Pcpt 3, minor)
When I went to get a check-up at my doctor’s
office. He asked my mom if she wanted me to
have the human papillomavirus shot. (Pcpt 10,
minor)
The doctor told me I had to take the vaccine.
(Pcpt 11, minor)

Provider Recommendation
Sixteen of the 30 participants stated that they
have seen a healthcare provider and have had a
discussion regarding the vaccine. Of the
remaining 14 participants, 12 stated that they
never received a recommendation from a
provider, and two stated that they could not
recall having such a discussion with any of their
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He [the doctor] told me that he had no
daughters…But if he had daughters, he would
highly recommend it [the vaccine]. (Pcpt 13,
minor)
I went for a routine check-up at the doctor’s
office, and she asked my parents if I wanted to
get an HPV shot. (Pcpt 20, minor)
I was at the doctor’s office and she
recommended that I took it [the vaccine]. (Pcpt
25, minor)
I went for school vaccine, and she [the nurse at
the Student Health Clinic] offered it [the
vaccine] to me. (Pcpt 15, young adult)

cancer prevention vaccine, parents had the
tendency to respond favorably to the provider
recommendation.
They say that I should take it [the vaccine], that
it would help prevent cervical cancer. She [my
mother] said “okay”, and she asked me if I was
fine with it. We had cancer in the family before,
and we lost a family member to cancer… I think
anything that deals with cancer, we take
precautions with that. It is hard to lose someone
[to cancer], and then to lose a child would even
be harder. (Pcpt 21, minor)
The doctor told my dad and me what the vaccine
was and what it was meant to prevent [cervical
cancer], as well as, the vaccine was
recommended for girls my age. I think just
because the doctor said it. I don’t think my dad
knows what HPV is. Once he [my father] heard
cancer, he decided on the vaccine to take
precautions. (Pcpt 3, minor)
He [doctor] just said it [the vaccine] was
important to try to prevent cervical cancer. I
think he could have explained more because he
just said it prevents cervical cancer and that was
it. He didn’t really go into details about it. She
[my mom] said that if it’s a health benefit then I
should take it. I wanted to take it, and it was my
decision. (Pcpt 5, young adult)

The 16 participants who had HPV vaccine
discussion were asked who was present at the
time of the discussion. Twelve had the HPV
vaccine discussion as minors and six had the
vaccine discussion as young adults while
attending college. All the participants who had
the conversation as minors (n=12) were with a
parent at the time of the recommendation. Nine
of them were with their mother. Of the
remaining three, one was with her father, one
with her stepmother, and one with both parents.
Of those six participants who had the vaccine
discussion as young adults while attending
college, three received the recommendation
from a nurse. Additionally, one of those six
participants was a young adult accompanied by
her mother at the time of the recommendation
(Pcpt 5).

More than half of the 16 participants received a
HPV vaccine recommendation that was not
framed as a cervical cancer prevention measure
but as a recommended vaccine for HPV
infection prevention (n=9). These messages
included information regarding the sexual
transmission route of the virus. Parents
responded positively when the sexual
transmission route was not emphasized. Two
participants pointed out that the physician
explained to their mothers that the virus was not
transmitted solely through sexual intercourse.
They stated that this information probably
influenced their mothers’ decision to get them
vaccinated. For the remaining seven participants,
several of them reported that their parents raised
side effect concerns due to the newness of the
vaccine compared to other adolescent vaccines
or declined it based on the sexual activity status
of the adolescent.
We were both in the office, and she [the doctor]
asked me if I wanted to take it [HPV vaccine].

HPV Message Framing and Vaccine Decision
Participants who received a physician
recommendation for the vaccine were asked to
comment on the HPV vaccine message they
received,
the
decision
following
the
recommendation, and specific details that led to
their vaccine decision. While more than half of
the young women had been recommended the
vaccine by a healthcare provider (n=16), the
framing of the vaccine recommendation was not
uniform, irrespective of the type of provider
(physician vs. nurse). Young women, adolescent
females, and their parents responded differently
to the recommendation depending on the
vaccine message framing. Less than half of the
healthcare providers framed the HPV vaccine as
a cervical cancer prevention vaccine (n=6).
When the message was framed as a cervical
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And she [the doctor] was explaining the benefits
of the vaccine and the symptoms of the infection
and the facts. And my mom was like “She does
not need it. I do not see a need for her to take
it.” So I did not take it at that time. My mom
knows I am not sexually active. That is why she
did not see a need for me to get it. I may take it,
but I am not sexually active right now. So, I
don’t see the need for it. (Pcpt 29, minor)
He [the doctor] just told us about HPV and that
the vaccine was fairly new. The vaccine was
offered to me when I was 15 turning 16 or just
turned 16. And she [my mom] was like “I am not
sure yet. Let’s see how everybody else reacts to
it. It is so new. You don’t know what happens
after people take it.” …. She was like “This is
my decision…As far as I know, you are not
sexually active, so I don’t think you need it.”
(Pcpt 17, minor)
He [doctor] was talking about it. He was like
“There is a shot for it, and it is better if you take
it than if you do not take it. You do not have to
be sexually active to get the virus. It is better to
take the vaccine if you are not engaged in sexual
activity than if you are. If you engaged in sexual
activity, the risk of infection is higher.” So
probably that is why my mom was like “Let me
[have the doctor] give it to the girls before they
get sexually active.” …We were talking about it,
but we did not make the decision right then and
there. I think we made the decision after a few
days to about a week. My mom was hesitant at
first because you know everyone has different
reaction to [the vaccine]. And she was like “It
is up to you if you want to do it. It does not
seem bad”. So, I thought about it and I was like
‘yeah’. And [we] went back to get it. (Pcpt 14,
minor)
When I went to get a check-up at my doctor’s
office they asked my mom if she wanted me to
have the human papillomavirus shot. It was the
same pediatrician’s office since I was a baby. I
think the doctor made her aware that it can be
transmitted sexually and in other ways too. she
decided it would be a good idea. She [my mom]
said “Sure, why not?” But since she’s adamant
about me not having sex in the near future, the
other ways probably concerned her more so
that’s why [she agreed]. (Pcpt 10, minor)

A few participants mentioned that their
healthcare provider recommended that they be
vaccinated against HPV if they were sexually
active (n=3). This message framing was not
received favorably among parents and
adolescent girls. Participants to whom the
vaccine was framed as such stated that they did
not receive the vaccine following the
recommendation. One participant stated that the
healthcare provider advised her to take the
vaccine if she was sexually active while her
mother was in the examination room. The
provider handed or pamphlet about HPV to the
adolescent. That participant specifically said
that she was discontented with the healthcare
provider discussing her sexual activity status in
her mother’s presence. A young woman who
received a vaccine message framed in this
manner declined the vaccine due to side effects
concerns based on a previous experience with
another vaccine and the fact that several trips
were required to complete the series.
The doctor said they had it [HPV vaccine]and if
I am sexually active she recommends that I take
it. She asked if I am sexually active. She [my
mother] looked at me to see what I was going to
say. I said I was not going to take the vaccine
because I am not sexually active, and I do not
plan to be sexually active anytime soon. And it
was kind of awkward. They gave me a pamphlet
and I just went home…She was having that
conversation with me in front of my mom. It was
weird. (Pcpt 28, minor)
I went to a clinic to do some basic check-up for
a job. A nurse asked me if I am interested in
getting the HPV vaccine. She asked me if I was
sexually active and I told her ‘I wasn’t’. She
asked me “Have [you] been in the past?” I told
her ‘yes’. She [a nurse] said I should get it [the
vaccine]. And she was like ‘Why not get it now
because it is better to get it now because if you
go and do have sex…. I thought ‘you know
what? This is something I need to think about’.
Because at the time I was not sexually active,
and I thought ‘Let me look into it, and then I
would make my decision’. She was trying to
convince me to get it, but I remembered the side
effects of the flu shot. …She explained the
potential side effects, and they were a little
scary…I knew I had to go back more than once,
and I did not want to go back more than once. I
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did not like that fact and had to think about it
because everything has advantages and
disadvantages. (Pcpt 8, young adult)

message, and she accepted it. However, being a
young adult, she viewed the decision as her own.
Higher vaccine acceptance has been reported
among young women when HPV message
framing focused on cervical cancer prevention
(Leader, Weiner, Kelly, Hornik, & Cappella,
2009). Additionally, another study showed that
more young men intended to get the vaccine
when it was framed as a cancer prevention
vaccine as compared to a genital warts
preventive measure (McRee, Reiter, Chantala, &
Brewer, 2010). One participant had lost a family
member to cancer, and her mother responded
positively to this framing. Women who
experience cervical disease or cervical cancer
are more highly motivated to have their
daughters vaccinated against HPV (Hamlish,
Clarke, & Alexander, 2012). Among participants
to whom the vaccine was framed in this manner,
a young adult mentioned the provider could have
provided more information. To ensure higher
vaccine acceptance, providers should take the
time to provide information regarding the
vaccine. Along with findings from the studies
cited above, these results indicate that the cancer
prevention framing increases HPV vaccine
acceptance and uptake.

Discussion
The goal of this study was to investigate the role
of healthcare providers’ recommendation style
in Haitian parents’ and female patients’ HPV
vaccine decision-making. Study participants
commented on the central role of provider
recommendation in their parents’ decision to get
them vaccinated as minors and in their own
decision to be vaccinated as young adults. This
finding is anticipated given that healthcare
provider recommendation has been consistently
associated with HPV vaccine uptake crossculturally (Jeudin et al., 2014; Mazza et al.,
2012; Perkins et al., 2012; Reiter et al., 2013;
Vadaparampil et al., 2014).
In this study, mothers were the primary parental
figure who most often accompanied their
daughters during their healthcare providers’
visit. Several studies have attested to the
important role of clinician-mother interaction in
HPV vaccine decision-making (Dempsey et al.,
2009; Gerend, Weibley, & Bland, 2009;
Griffioen et al., 2013). Following the motherclinician conversation about the vaccine,
generally, the mothers shared their endorsement
of the vaccine with their daughters and told them
to take it or they expressed the opposition or
concern directly to the provider.

A group of providers framed the vaccine as a
preventive measure against HPV infection and
informed parents and participants that the virus
was transmitted sexually. Two participants
reported that their physicians emphasized that
HPV is not transmitted only through sexual
intercourse. Parents did not oppose the vaccine
when messages were framed in this manner.
Upon hearing that the virus was not transmitted
solely through sexual intercourse, the mothers
consented for the vaccine. Although HPV has
been detected in vaginal swabs from virginal
women (Bumbuliene, Alisauskas, & Sepetiene,
2011; Eleutério et al., 2013; Winer et al., 2003),
participants did not comment on the other
potential route of transmission and were not
probed further to assess whether the providers
explained the other potential routes of
transmission. Nevertheless, informing parents
that the virus was not transmitted solely through
sexual intercourse convinced them to get their
daughters vaccinated. Other participants to
whom the vaccine was framed as a

Study findings revealed that recommendation
style varied among healthcare providers, and is
of crucial importance in HPV vaccine decisionmaking. Some healthcare providers framed the
vaccine as a cervical cancer prevention vaccine.
This framing was well-received by Haitian
parents, and they often perceived the vaccine as
beneficial. These results concur with those of a
previous study that reported significantly higher
intentions among mothers to get their daughter
vaccinated following a HPV vaccine message
focusing on cervical cancer protection (Lechuga
et al., 2011). In our study, a participant receives
a recommendation framed in this manner as a
young adultaccompanied by her mother. Her
mother endorsed the vaccine following the
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recommended vaccine for a sexually transmitted
infection reported that their parents responded
by raising safety concerns because the HPV
vaccine has not been licensed for as long as the
other adolescent vaccines or by informing the
providers that their daughters did not need the
vaccine. Previous studies have reported side
effect concerns among parents (Laz, Rahman, &
Berenson, 2012; Sanders Thompson, Arnold, &
Notaro, 2012; Wilson et al., 2013). In this study,
parents often raised side effects questions when
the benefits of the vaccine were not emphasized.

resources and information outside of their
familial and community spaces. Thus, these
women represented a population that is
distinctly different from community samples that
may face greater barriers to seeking health
services and information or that may have lower
English proficiency. Additionally, the exact
timing of participant’s encounter with their
provider was not captured. We simply captured
whether the participants’ encounter with the
healthcare provider occurred while they were a
minor or a young adult. Thus, recall bias may
influence our results. Moreover, participants
often alluded to the gender of the provider and
sometimes provided the specialty, but provider
demographics were not collected in the study.
Future research should examine the role of the
provider’s gender and ethnicity, as such research
might provide additional insights into the
patient-provider
and
mother-provider
interactions. A few participants stated that the
provider informed their parents that HPV could
be transmitted through means other than sexual
intercourse. However, we did not ask
participants whether the providers stated the
other potential means of transmission, and such
information would provide rich details regarding
the message framing. Furthermore, some
participants mentioned their sexual activity
status at the time of the recommendation, but
their sexual activity status at the time of the
study and at the time of the recommendation
was not collected due to the sensitivity of this
issue in the Haitian culture. Therefore,
participants could not be probed specifically
about the influence of their sexual activity status
on their vaccine decision-making. Despite these
limitations, this study provides an important first
step towards adding to what is currently a very
small body of research addressing the role of
healthcare providers’ recommendation style in
HPV vaccine decision-making processes among
Haitian parents and female patients.

A few providers asked participants about their
sexual activity status before recommending the
vaccine. When the vaccine was framed as a
preventative measure for sexually active
individuals, the vaccine recommendation was
not received favorably by the parents or the
adolescents. The vaccine was often declined
when it was framed in this manner. Existing
literature has reported that young Haitian
women are expected to remain virgins until
marriage (Archibald, 2007; Stephens & Thomas,
2013). Parents may experience difficulties in
encouraging preventive practices if such
practices are strongly linked to sexual behaviors
when there are cultural expectations of chastity
for girls. In this context, discussing sexual
activity status may negatively affect patientclinician, mother-clinician, and parent-daughter
relationships. This message framing is likely to
be met with resistance, as it is not congruent
with Haitian cultural values. However, in the
example given of Participant 8, to whom the
vaccine was framed as such, she was not with a
parent at the time of the recommendation, and
she did not explicitly report feeling offended.
Nevertheless, the framing of the discussion was
not effective in motivating her to receive the
vaccine.
This study focused on the role of healthcare
providers’ recommendation style in Haitian
parents’ and female patients’ HPV vaccine
decision-making in a region where there is a
large Haitian population. As students at a large
minority serving state university, they have
access to a university health center that includes
a clinic specifically serving women’s sexual
health needs. They can seek out sexual health

Implications for Practice
Across
cultures
and
ethnic
groups,
recommendation from a healthcare provider is a
highly influential factor in HPV vaccine uptake.
This study suggests that HPV recommendation
framing had a great influence on mothers’ HPV
vaccine decision for their daughter, and young
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Haitian women’s decision to be vaccinated.
Thus, it is important for healthcare providers to
understand that the message framing is as
important as the recommendation, and that a
message framing that is not appropriate can
result in missed opportunities for vaccination.
Presenting HPV vaccine as a HPV-related
cancer or cervical cancer preventive vaccine
may motivate parents and young women to
consider the long-term benefits of the vaccine.
Should providers prefer to present the vaccine to
Haitian parents as a preventive measure against
HPV infection, they should explain the link
between the virus cancer and should avoid
emphasizing the sexual transmission route.
Considering the cultural taboo of discussing sex
with Haitian teens primarily in the presence of
parents, it may be more useful and comfortable
for health providers to discuss teens’ sexual
activity outside of parents’ presence. In the
presence of a Haitian parent, framing HPV
vaccine as a STI preventive vaccine for the
sexually active will severely reduce vaccine
acceptability for the adolescent. If accompanied
by a parent and the vaccine is framed as a STI
preventive measure for the sexually active, a
young Haitian woman would not feel
comfortable accepting the vaccine should she be
sexually active, as young Haitian women are
expected to remain virgins until marriage
(Archibald, 2007; Stephens & Thomas, 2013).
Additionally, providers should be reminded that
teens’ level of sexual activity is not relevant to
vaccine recommendation. Providers should
refrain from asking patients about their sexual
activity status in the context of HPV vaccine
recommendation. Instead, providers should

emphasize that the vaccine is best taken prior to
initiating sexual activity. The vaccine is
recommended for adolescents and young adults
ideally prior to their initiation of sexual activity,
and providers should recommend it that way.
Recommending the vaccine specifically to
sexually active individuals may lead to the
conclusion that the vaccine is for the sexually
promiscuous and would likely result in a missed
opportunity for vaccination. Moreover, future
studies should investigate parents’ and young
adults’
response
to
HPV
vaccine
recommendation from nurses and physician
assistants, as a few participants had received a
recommendation for the vaccine from nurses in
settings other than doctor’s office.
Conclusion
Cross-culturally,
healthcare
provider
recommendation plays a crucial role in
influencing HPV vaccine uptake. As evidenced
by these findings, provider recommendation
style influences parents’ and female patients’
decision-making following the provider
recommendation. Consequently, when framing
the HPV vaccine messages, healthcare providers
should consider the patient’s culture as
culturally inappropriate vaccine messages can
reduce vaccine acceptability. Additionally,
providers should invite parents as well as the
adolescents to ask any questions and raise any
concerns they may have, and that would be an
opportunity to provide additional information,
refute vaccine misconceptions, and address side
effect concerns.
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Appendix I
Interview Guide Sample Questions
Part A: HPV Knowledge
1. Have you ever heard of Human Papillomavirus or HPV?
2. Where/how did you hear about it? What is HPV?
Part B: Knowledge of HPV vaccine
1. Have you ever heard of Human Papillomavirus or HPV vaccine?
2. What do you know about the vaccine? Who should get it?
Part C: Attitudes
1. What do you think about the vaccine?
2. How do you feel about getting the vaccine?
Part D: Acceptability and Uptake
1. Have you initiated the HPV vaccine?
If yes: How many doses have you completed? At what age did you get vaccinated?
Part E: Factors influencing vaccine decision (If participants answered yes to Part D)
1. What/who motivated to get the vaccine? Walk me through the decision-making process.
2. Has a provider recommended that you take the vaccine? What did the provider say? What
information did s/he provide? How did you (your parent) react following the recommendation?
Follow-up questions based on age at the time of recommendation and vaccination, individuals involved
in decision-making, HPV-related conversations in the household, and sexuality-related conversations in
the household.
Part F: Factors influencing vaccine decision (If participants answered no to Part D)
1. What/who do you think influenced/discouraged you to not get the vaccine? Walk me through
the decision-making process.
2. Has a provider recommended that you take the vaccine? Do you have a primary healthcare
provider? Have you ever asked your healthcare provider about HPV vaccine? Why (not)?
Follow-up questions based on age at the time of recommendation and vaccination, individuals involved
in decision-making, HPV-related conversations in the household, and sexuality-related conversations in
the household.
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